Unlocking the potential of pyroptosis in tumor immunotherapy: a new horizon in cancer treatment
The interplay of pyroptosis pathways and immune cell activation in tumor immunity. The diagram illustrates the orchestrated pathways of pyroptosis, a form of cell death that contributes to tumor immunity by engaging various immune cells and inflammatory processes. Initiation of pyroptosis can occur through different mechanisms: the canonical inflammasome pathway, which is activated by DAMPs and PAMPs leading to NLRP3 inflammasome assembly and caspase-1 activation; and the non-canonical inflammasome pathway, initiated by factors such as LPS and recognized by TLR4, activating caspase-4/5/11. These pathways converge on the cleavage of GSDMD, resulting in the formation of pores in the cell membrane and cell lysis. CTLs and NK cells secrete granzymes that cleave GSDME and GSDMB, further propagating pyroptosis. Active caspase-3, influenced by signals such as TNF-α, antibiotics, and chemotherapy, also contributes to the activation of GSDME and GSDMC, leading to cell rupture. The outcome is the release of pro-inflammatory cytokines (IL-1β, IL-18, IL-22, HMGB1) and danger signals that prompt the recruitment and activation of various immune cells, including dendritic cells (DCs), CD4+ T cells, CD8+ T cells, and myeloid-derived suppressor cells (MDSCs). This immunological response culminates in a heightened anti-tumor activity, as the activated immune cells induce further pyroptosis in the cancer cells, creating a feedback loop that amplifies the anti-tumor immune response. The representation captures the complexity of pyroptosis and its significant role in enhancing the efficacy of immune-mediated cancer therapies.
Publication
Unlocking the potential of pyroptosis in tumor immunotherapy: a new horizon in cancer treatment. (2024) Qinan Yin, et al. Front Immunol. 2024;15:1381778. Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | PD-L1 | PD-L1 | ncbigene_synonym | CD274 | 29126 |
| Homo sapiens | Primates | TNF-a | TNF-A | ncbigene_synonym | TNF | 7124 |
| Homo sapiens | Primates | TNFR | TNFR | ncbigene_synonym | TNFRSF1A | 7132 |
| Homo sapiens | Primates | LPS | LPS | ncbigene_synonym | IRF6 | 3664 |
| Homo sapiens | Primates | GzmB | GZMB | ncbigene_symbol | GZMB | 3002 |
| Homo sapiens | Primates | GzmA | GZMA | ncbigene_symbol | GZMA | 3001 |
| Homo sapiens | Primates | NLRP3 | NLRP3 | ncbigene_symbol | NLRP3 | 114548 |
| Homo sapiens | Primates | AIM2 | AIM2 | ncbigene_symbol | AIM2 | 9447 |
| Homo sapiens | Primates | ASC | ASC | ncbigene_synonym | STS | 412 |
| Homo sapiens | Primates | ASC | ASC | ncbigene_synonym | PYCARD | 29108 |
| Homo sapiens | Primates | ATP | ATP | ncbigene_synonym | ATP8A2 | 51761 |
| Homo sapiens | Primates | IRF8 | IRF8 | ncbigene_symbol | IRF8 | 3394 |
| Homo sapiens | Primates | GSDMD | GSDMD | ncbigene_symbol | GSDMD | 79792 |
| Homo sapiens | Primates | IL-1a | IL-1A | ncbigene_synonym | IL1A | 3552 |
| Homo sapiens | Primates | GSDMC | GSDMC | ncbigene_symbol | GSDMC | 56169 |
| Homo sapiens | Primates | GSDME | GSDME | ncbigene_symbol | GSDME | 1687 |
| Homo sapiens | Primates | GSDMB | GSDMB | ncbigene_symbol | GSDMB | 55876 |
| Homo sapiens | Primates | IL-18 | IL-18 | ncbigene_synonym | IL18 | 3606 |
| Homo sapiens | Primates | IL-1ẞ | IL1 | ncbigene_synonym | IL1B | 3553 |
| Homo sapiens | Primates | interferon | INTERFERON | famplex_relations | IFNK | 56832 |
| Homo sapiens | Primates | interferon | INTERFERON | famplex_relations | IFNW1 | 3467 |
| Homo sapiens | Primates | interferon | INTERFERON | famplex_relations | IFNA1 | 3439 |
| Homo sapiens | Primates | interferon | INTERFERON | famplex_relations | IFNA2 | 3440 |
| Homo sapiens | Primates | interferon | INTERFERON | famplex_relations | IFNA4 | 3441 |
| Homo sapiens | Primates | interferon | INTERFERON | famplex_relations | IFNA5 | 3442 |
| Homo sapiens | Primates | interferon | INTERFERON | famplex_relations | IFNA6 | 3443 |
| Homo sapiens | Primates | interferon | INTERFERON | famplex_relations | IFNA7 | 3444 |
| Homo sapiens | Primates | interferon | INTERFERON | famplex_relations | IFNA8 | 3445 |
| Homo sapiens | Primates | interferon | INTERFERON | famplex_relations | IFNA10 | 3446 |
| Homo sapiens | Primates | interferon | INTERFERON | famplex_relations | IFNA13 | 3447 |
| Homo sapiens | Primates | interferon | INTERFERON | famplex_relations | IFNA14 | 3448 |
| Homo sapiens | Primates | interferon | INTERFERON | famplex_relations | IFNA16 | 3449 |
| Homo sapiens | Primates | interferon | INTERFERON | famplex_relations | IFNA17 | 3451 |
| Homo sapiens | Primates | interferon | INTERFERON | famplex_relations | IFNA21 | 3452 |
| Homo sapiens | Primates | interferon | INTERFERON | famplex_relations | IFNB1 | 3456 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| dsDNA | dsDNA | dsDNA | chebi:4705 | |
| TNF-a | TNF-a | chebi:197439 | ||
| LPS | LPS | chebi:89981 | ||
| ATP | ATP | ATP | chebi:30616 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|